A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

Nativis Voyager RFE Therapy

Nativis Voyager Radiofrequency Energy Therapy

Trial Locations (13)

33486

Boca Raton Regional Hospital, Boca Raton

35233

University of Alabama at Birmingham (UAB), Birmingham

66205

University of Kansas Medical Center (KUMC), Kansas City

76508

Baylor Scott & White Health, Temple

78705

Cancer Care Collaborative, Austin

85718

Center for Neurosciences, Tucson

90404

John Wayne Cancer Institute @ Providecne St. Johns Health Center, Santa Monica

92024

cCARE - California Cancer Associates for Research & Excellence, Encinitas

97225

Providence Brain & Spine Institute, Portland

98101

Virginia Mason Hospital & Medical Center, Seattle

98122

Swedish Medical Center, Seattle

06824

Associated Neurologists of Southern CT, P.C., Fairfield

Unknown

St Vincent's Hospital Melbourne, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nativis, Inc.

INDUSTRY